Know Cancer

or
forgot password

A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-Positive Cases in Squamous Cell Carcinoma of the Head and Neck


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Squamous Cell

Thank you

Trial Information

A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-Positive Cases in Squamous Cell Carcinoma of the Head and Neck


Inclusion Criteria:



- Histologically proven squamous cell carcinoma

- Larynx & pharynx (except Nasopharyngeal carcinoma)

- Stage III & IV, but any stage hypopharynx

- Informed Consent

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

John Waldron, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

UHN REB 01-0557-C

NCT ID:

NCT00188318

Start Date:

June 1998

Completion Date:

Related Keywords:

  • Carcinoma, Squamous Cell
  • Carcinoma
  • Carcinoma, Squamous Cell

Name

Location